Author Archives: Broad Hollow Bioscience Park

14
Dec
Date December 14, 2023
Author Broad Hollow Bioscience Park

New 200,000-Square-Foot Cell and Gene Therapy Hub Coming to Lake Success

A 15-acre site in Lake Success will soon host a 200,000-square-foot cell and gene therapy research hub, backed by up to $150 million in state funding. The project aims to support startups, create hundreds of jobs, and propel Long Island's life sciences sector. The hub will include a business incubator to help bring scientific discoveries to market.
Read More
Author Broad Hollow Bioscience Park
16
Oct
Date October 16, 2023
Author Broad Hollow Bioscience Park

Accelerate Long Island: Funding Support for Bootstrapping Entrepreneurs

Accelerate Long Island offers $130,000 in grants to support bootstrapping tech entrepreneurs with essential professional services like legal, accounting, HR, and marketing. Funded by a $1.25 million, five-year grant from Empire State Development, this program helps early-stage startups gain momentum. Applications are open to tech startups less than five years old with under $1 million in equity.
Read More
Author Broad Hollow Bioscience Park
21
Feb
Date February 21, 2023
Author Broad Hollow Bioscience Park

Codagenix Secures $25 Million in New Funding to Advance Covid Vaccine Trials

Codagenix Inc. has raised an additional $25 million, bringing its total funding to $45 million, to support its vaccine development efforts. This new round includes contributions from Serum Institute of India and existing investors Euclidean Capital and Adjuvant Capital. The funding will advance phase 1 trials for the CodaVax-RSV vaccine targeting respiratory syncytial virus and the CodaVax-H1N1 influenza vaccine. Codagenix, based at Farmingdale State College’s Broad Hollow Bioscience Park and in Cambridge, Massachusetts, utilizes cutting-edge synthetic biology to create innovative vaccines. The company is also involved in a WHO study of its CoviLiv nasal COVID-19 vaccine.
Read More
Author Broad Hollow Bioscience Park
28
Sep
Date September 28, 2022
Author Broad Hollow Bioscience Park

Long Island’s Life Sciences Revival: New Investments and Strategic Moves

After a challenging decade following OSI Pharmaceuticals' departure, Long Island is seeing a revival in its life sciences sector. Estee Lauder has joined Farmingdale State College’s Broadhollow Bioscience Park as an anchor tenant, and Dan Polner has been appointed as the park's new executive director. Governor Kathy Hochul has announced $10 million in funding for Feinstein Institutes for Medical Research and an additional $50 million for a life sciences competition for local startups. With these investments and a renewed focus on coordination among key institutions, Long Island aims to transform its life sciences vision into reality.
Read More
Author Broad Hollow Bioscience Park
22
Sep
Date September 22, 2022
Author Broad Hollow Bioscience Park

Broadhollow Bioscience Park Pioneers Long Island’s Life Sciences Renaissance

Broadhollow Bioscience Park is revitalizing Long Island's life sciences sector. With Estee Lauder as a new anchor tenant and Dan Polner as executive director, the park is set to expand. Governor Kathy Hochul’s Long Island Investment Fund (LIIF) recently allocated $60 million to bolster local biotech startups and research institutions. Plans for a new 60,000-square-foot facility aim to strengthen collaborations with top institutions like Brookhaven National Laboratory and Stony Brook University. These initiatives position Broadhollow to drive innovation, create jobs, and boost the regional economy.
Read More
Author Broad Hollow Bioscience Park
17
Feb
Date February 17, 2022
Author Broad Hollow Bioscience Park

Leveraging Estée Lauder’s Move to Fuel Long Island’s Biotech Sector

Long Island's biotechnology sector has faced numerous challenges, but recent developments offer a fresh opportunity. Estée Lauder's decision to become the new anchor tenant at Broad Hollow Bioscience Park brings renewed hope, with plans for research labs and 31 new jobs. However, the region’s biotech ambitions have historically faltered, with past setbacks including the departures of Helicon Therapeutics and OSI Pharmaceuticals. To turn this new chance into long-term success, Long Island must attract more life sciences firms, leverage local research resources, and foster strong regional collaboration. The next five years will be pivotal in determining whether this latest effort can finally build a thriving biotech industry.
Read More
Author Broad Hollow Bioscience Park
09
Feb
BHBP
Date February 9, 2022
Author Broad Hollow Bioscience Park

Estée Lauder to Establish Research Lab at Farmingdale State, Boosting Jobs and Student Support

Estée Lauder is set to enhance Long Island's biotech landscape with a new research laboratory and office at Farmingdale State College’s Broad Hollow Bioscience Park. Opening in the spring, this facility will employ up to 80 people, including 31 new positions, and contribute $1.75 million to the college for scholarships. The lab will focus on skincare, makeup, and fragrance innovations, involving students in hands-on research and training. This development, supported by $1.2 million in tax credits from Empire State Development, aims to revitalize the Broad Hollow park and strengthen regional economic ties between academia and industry.
Read More
Author Broad Hollow Bioscience Park
19
Jun
Date June 19, 2018
Author Broad Hollow Bioscience Park

Farmingdale’s BF Innovation Joins Start-Up NY Tax-Free Program

BF Innovation Inc., a skin-care product developer located in Farmingdale’s Broad Hollow Bioscience Park, has joined Gov. Andrew M. Cuomo’s Start-Up NY tax-free zones program. This participation exempts the company from state and local taxes for up to 10 years and offers state income tax exemptions to its new employees for the same period. The company focuses on developing topical drug products for dermatitis and aims to double its workforce by year-end. BF Innovation is the fourth Start-Up NY participant at Farmingdale State College’s zone, joining other biotech startups.
Read More
Author Broad Hollow Bioscience Park
14
Apr
Date April 14, 2011
Author Broad Hollow Bioscience Park

New Law Aims to Secure OSI Pharmaceuticals’ Future on Long Island

Gov. Andrew M. Cuomo has signed a bill enabling OSI Pharmaceuticals Inc. to expand its operations at Farmingdale State College. The legislation, which passed with overwhelming support in the State Senate and Assembly, establishes the boundaries for the college's Broad Hollow Bioscience Park at 38.5 acres and allows for the construction of a third building. This new structure will house start-up companies while OSI expands into an existing building. The move is expected to create 135 jobs at the college, bolstering Long Island's biotechnology sector.
Read More
Author Broad Hollow Bioscience Park
23
Mar
Date March 23, 2011
Author Broad Hollow Bioscience Park

Expansion of Farmingdale State College’s Business Incubator Approved by State Senators

State senators have approved a bill to expand the business incubator at Farmingdale State College, a significant move aimed at boosting the local biotechnology sector. The legislation designates 38.5 acres for the Broad Hollow Bioscience Park and facilitates the construction of a third building to house start-up companies, with OSI Pharmaceuticals expanding into an existing second building. OSI, known for its lung cancer drug Tarceva, plans to create approximately 135 new jobs. The bill also exempts park tenants from state construction and procurement laws, simplifying development processes. This expansion is expected to drive economic growth and innovation in Long Island's biotechnology industry.
Read More
Author Broad Hollow Bioscience Park
1 2